Seoul National University Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Seoul National University Hospital takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on breast cancer and new drug development. It covers treatment before surgery for triple-negative early breast cancer and new strategies for antibody-drug conjugates.

OrganizationESMO 2026 Attendance
Seoul National University Hospital
Seoul, Republic of Korea
Cancer centre & hospital
Teaching hospital of Seoul National University College of Medicine in Seoul, South Korea.
Chair
Sat Oct 24
08:30–10:00
Proffered paper 2: Breast cancer, early and advanced stage
with University of Washington
Breast cancer
Talk
Sat Oct 24
15:05–15:25
Neoadjuvant therapy for TNBC
Optimising treatment for triple negative early breast cancer
Breast cancer
Chair
Sun Oct 25
10:15–11:45
Talk
Sun Oct 25
10:30–10:45
ADCs: New strategies
Emerging concepts in developmental therapeutics

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Seoul National University Hospital

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction